What should you know about immunotherapy treatment for lung cancer?

Immunotherapy medicines target immune checkpoints, which can act like brakes on immune-cell activity. Removing some of these brakes may help immune cells identify and attack cancer cells. The plan differs between non-small cell and small cell lung cancer and can depend on stage, tumour features, symptoms, previous treatment and general health.

Treatment may be given alone or alongside chemotherapy, depending on the clinical plan. Radiotherapy can target a particular area, such as a tumour causing pain or pressure. The team weighs expected benefit against possible immune effects on organs such as the lungs, bowel, liver, skin, thyroid and heart.

Before starting, tell the team about autoimmune disease, organ transplants, lung conditions, current medicines and previous cancer treatment. At visits, report changes in cough, breathing, bowel habit, skin, energy, appetite, urine, vision or mood. Blood tests and scans help the team assess treatment effects and the cancer response.

Keep your oncology contact details available and ask what to do outside clinic hours. Do not take a new supplement, delay an appointment or stop treatment without discussing it with the treating team.

Call your oncology service promptly for new breathlessness, worsening cough, chest pain, persistent diarrhoea, severe abdominal pain, yellowing of the eyes, a spreading rash, unusual weakness or reduced urine. Seek emergency help for sudden breathing difficulty, fainting, severe chest pain, facial swelling or confusion. Tell emergency staff that you are receiving immunotherapy.

Which type of lung cancer do I have, and why is immunotherapy being considered? Will it be combined with chemotherapy or radiotherapy? Which symptoms need same-day advice? How will scans and blood tests guide treatment? Who should I call overnight or at weekends?